Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0O7QA
|
||||
| Former ID |
DIB012012
|
||||
| Drug Name |
PF-05089771
|
||||
| Synonyms |
Nav1.7 blockers (pain), Pfizer; SCN9A blockers (pain), Pfizer/Icagen/Birkbeck; Voltage-gated sodium channel 1.7 blockers (pain), Pfizer
|
||||
| Indication | Chronic pain [ICD9: 338.2,780; ICD10:R52.1-R52.2, G89] | Phase 2 | [523792] | ||
| Company |
Pfizer
|
||||
| Target and Pathway | |||||
| Target(s) | Voltage-gated sodium channel subunit alpha Nav1.7 | Target Info | Blocker | [533324] | |
| Reactome | Interaction between L1 and Ankyrins | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.